1. Home
  2. LWLG vs RCEL Comparison

LWLG vs RCEL Comparison

Compare LWLG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LWLG
  • RCEL
  • Stock Information
  • Founded
  • LWLG 1991
  • RCEL 2020
  • Country
  • LWLG United States
  • RCEL United States
  • Employees
  • LWLG N/A
  • RCEL N/A
  • Industry
  • LWLG Containers/Packaging
  • RCEL Medical/Dental Instruments
  • Sector
  • LWLG Industrials
  • RCEL Health Care
  • Exchange
  • LWLG Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • LWLG 333.2M
  • RCEL 310.6M
  • IPO Year
  • LWLG N/A
  • RCEL N/A
  • Fundamental
  • Price
  • LWLG $2.88
  • RCEL $11.95
  • Analyst Decision
  • LWLG
  • RCEL Hold
  • Analyst Count
  • LWLG 0
  • RCEL 3
  • Target Price
  • LWLG N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • LWLG 739.8K
  • RCEL 99.4K
  • Earning Date
  • LWLG 11-13-2024
  • RCEL 11-07-2024
  • Dividend Yield
  • LWLG N/A
  • RCEL N/A
  • EPS Growth
  • LWLG N/A
  • RCEL N/A
  • EPS
  • LWLG N/A
  • RCEL N/A
  • Revenue
  • LWLG $113,190.00
  • RCEL $60,040,000.00
  • Revenue This Year
  • LWLG N/A
  • RCEL $34.73
  • Revenue Next Year
  • LWLG N/A
  • RCEL $54.61
  • P/E Ratio
  • LWLG N/A
  • RCEL N/A
  • Revenue Growth
  • LWLG N/A
  • RCEL 32.24
  • 52 Week Low
  • LWLG $2.44
  • RCEL $7.51
  • 52 Week High
  • LWLG $5.69
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • LWLG 41.12
  • RCEL 57.86
  • Support Level
  • LWLG $2.80
  • RCEL $11.16
  • Resistance Level
  • LWLG $3.90
  • RCEL $13.37
  • Average True Range (ATR)
  • LWLG 0.26
  • RCEL 0.72
  • MACD
  • LWLG -0.09
  • RCEL 0.12
  • Stochastic Oscillator
  • LWLG 7.27
  • RCEL 57.23

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: